Camelia Quek

Dr Camelia Quek is a NHMRC Investigator Fellow, Senior Translational Computational Scientist at Melanoma Institute Australia and an Adjunct Associate Professor at the University of Sydney. She originally did a first degree in molecular biology at the University of New South Wales (University Medal) before moving on to do a PhD in transcriptomics and bioinformatics at the University of Melbourne (Sawyer Medal). She specialises in clinical computational biology and has wide experience in clinical multi-omics analytics and spatial data integration. Dr Quek’s early research has made significant advances in understanding cancer biology and tumour microenvironment in melanoma patients treated with immunotherapy, using gene expression profiles to discover biomarkers in response to cancer therapies, and single-cell multi-omics to guide clinical decision-making. Her research impact and contributions are recognised in Australia and worldwide. Over the past years, she has received several prestigious awards including 2022 CINSW Premier’s Awards for Wildfire Highly Cited Publication (co-first authors, Cancer Cell 2019), 2021 10x Millennium Science Start Single Cell Award, and 2017 CINSW Premier’s Awards for Excellence in Translational Research Team. She has also received 3X Best Poster Winner and 2X Best Oral Talk at both international and national conferences. Passionate about translating research findings into clinical and industrial applications, she actively collaborates with clinicians and industry partners to advance new knowledge in the design of biomarker panels and therapeutic targets.